NIH-funded research R01 grant

New roles for a heart protein in preventing dangerous rhythms

Official title: Novel Roles of Protein phosphatase 2A in Cardiac Arrhythmia

Funded at Ohio State University · NIH-11375997 · Data updated 2026-11-12

A heart study will explore how a specific protein regulator (PP2A) affects ion channels that control heartbeat, with the goal of reducing dangerous arrhythmias.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startJuly 1, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$626,400
NIH project number5R01HL175380-03
Project IDNIH-11375997 on NIH RePORTER

Who could benefit from this research

Could help

People with or at risk for arrhythmias, especially those linked to INa,L abnormalities or adrenergic stress, could benefit from future therapies

Less likely to help

Patients without arrhythmia risk related to INa,L regulation may see little direct benefit

What this research studies

This project looks at how the protein PP2A, through its B56α subunit, influences the Nav1.5 sodium channel in heart cells, especially during stress. By understanding how negative regulation of the late INa,L current works, researchers aim to identify ways to prevent fatal fast heart rhythms. The study combines cellular and animal models to map where these proteins come together in heart tissue and how adrenergic challenges change their interactions. The findings could inform strategies to target this pathway and reduce sudden cardiac death risk.

Why it matters

Potential benefit: If successful, the research may lead to new approaches to lower the risk of life-threatening arrhythmias in patients.

How similar studies have gone: Previous work shows that modulating the B56α-PP2A pathway can affect Nav1.5 activity and INa,L, supporting potential of this approach

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: El Refaey, Mona — Ohio State University
  • Study coordinator: El Refaey, Mona

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.